- Home
- GHRS vs LIND Comparison
GHRS vs LIND Comparison
Compare GHRS & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- LIND
- Stock Information
- Founded
- GHRS 2018
- LIND 1979
- Country
- GHRS Ireland
- LIND United States
- Employees
- GHRS N/A
- LIND N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- LIND Transportation Services
- Sector
- GHRS Health Care
- LIND Consumer Discretionary
- Exchange
- GHRS Nasdaq
- LIND Nasdaq
- Market Cap
- GHRS 583.1M
- LIND 502.2M
- IPO Year
- GHRS 2021
- LIND N/A
- Fundamental
- Price
- GHRS $10.60
- LIND $10.44
- Analyst Decision
- GHRS Strong Buy
- LIND Strong Buy
- Analyst Count
- GHRS 8
- LIND 3
- Target Price
- GHRS $30.63
- LIND $15.67
- AVG Volume (30 Days)
- GHRS 146.4K
- LIND 302.7K
- Earning Date
- GHRS 05-08-2025
- LIND 05-06-2025
- Dividend Yield
- GHRS N/A
- LIND N/A
- EPS Growth
- GHRS N/A
- LIND N/A
- EPS
- GHRS N/A
- LIND N/A
- Revenue
- GHRS N/A
- LIND $670,834,000.00
- Revenue This Year
- GHRS N/A
- LIND $12.38
- Revenue Next Year
- GHRS N/A
- LIND $10.15
- P/E Ratio
- GHRS N/A
- LIND N/A
- Revenue Growth
- GHRS N/A
- LIND 15.71
- 52 Week Low
- GHRS $6.00
- LIND $6.76
- 52 Week High
- GHRS $20.50
- LIND $14.34
- Technical
- Relative Strength Index (RSI)
- GHRS 59.36
- LIND 66.87
- Support Level
- GHRS $9.81
- LIND $9.34
- Resistance Level
- GHRS $11.50
- LIND $10.68
- Average True Range (ATR)
- GHRS 0.72
- LIND 0.49
- MACD
- GHRS 0.23
- LIND 0.26
- Stochastic Oscillator
- GHRS 89.60
- LIND 82.31
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About LIND Lindblad Expeditions Holdings Inc.
Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.